Nomura Holdings
ALT icon

Nomura Holdings’s Altimmune ALT Stock Holding History

Nomura Holdings’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-273,100
Closed -$710K – 1763
2023
Q3 		$710K Hold
273,100
– – ﹤0.01% 1059
2023
Q2 		$964K Buy
273,100
+249,900
+1,077% +$1.12M ﹤0.01% 922
2023
Q1 		$97.9K Buy
+23,200
New +$276K ﹤0.01% 1299

Other funds holding ALT

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

Nomura Holdings's ALT Position: Q4 2023 in Review

Nomura Holdings sold out of Altimmune (ALT) in Q4 2023, closing a stake of 273,100 shares — an estimated $710K sold.

Nomura Holdings first reported a position in ALT in Q1 2023 and held it in 3 quarters. The position peaked at $964K in Q2 2023. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.

  • Nomura Holdings reported no remaining Altimmune position as of Q4 2023 after selling out during the quarter.
  • Nomura Holdings sold 273,100 Altimmune shares in Q4 2023, an estimated $710K.
  • Nomura Holdings first reported a position in Altimmune in Q1 2023 and held it in 3 quarters.
  • Nomura Holdings's Altimmune position peaked at $964K in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.

Based on Nomura Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.